Clinical Trial Update: Maraviroc Compassionate Use [Phase 3]

View source ↗

Summary

A Phase 3 compassionate-use trial of Maraviroc for HIV-1 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Selzentry (Maraviroc)

Snippet

Sponsor: ViiV Healthcare | Conditions: Human Immunodeficiency Virus Type 1 | Phase 3 | Status: WITHDRAWN